title: Ibandronate improves hyperphosphatemia in dialysis patients with hyperparathyroidism.
authors.forename: C G
authors.initials: CG
authors.lastname: Musso
authors.forename: R
authors.initials: R
authors.lastname: Guelman
authors.forename: F
authors.initials: F
authors.lastname: Varela
authors.forename: R
authors.initials: R
authors.lastname: Pidoux
authors.forename: C
authors.initials: C
authors.lastname: Schreck
authors.forename: G
authors.initials: G
authors.lastname: RosaDiez
authors.forename: L
authors.initials: L
authors.lastname: Plantalech
authors.forename: L
authors.initials: L
authors.lastname: Algranati
mesh_terms: D004164:Diphosphonates / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006961:Hyperparathyroidism / Q000150:complications* / Q000188:drug therapy*; D000077557:Ibandronic Acid; D008875:Middle Aged; D010710:Phosphates / Q000097:blood*; D006435:Renal Dialysis
chemical_list: D004164:Diphosphonates; D010710:Phosphates; D000077557:Ibandronic Acid